---
schema_version: "secwatch.filing_event.v1"
accession: "0001372514-23-000160"
form_type: "8-K"
ticker: "KPRX"
cik: "0001372514"
company_name: "KIORA PHARMACEUTICALS INC"
filed_at: "2023-11-09T23:59:59+00:00"
generated_at: "2026-06-08T06:18:46.076095+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Kiora Pharmaceuticals furnishes updated investor presentation with no specific new facts disclosed

## Summary
- Filed under Item 7.01 and 9.01; presentation provided as Exhibit 99.1.
- No financial guidance, operational milestones, or clinical data disclosed in the filing.
- The presentation may be used for investor meetings; content not detailed in this 8-K.
- Ticker: KPRX; sentiment neutral due to lack of material new information.

## SEC filing metadata
- accession: 0001372514-23-000160
- form_type: 8-K
- ticker: KPRX
- cik: 0001372514
- company_name: KIORA PHARMACEUTICALS INC
- filed_at: 2023-11-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1372514/000137251423000160/0001372514-23-000160-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1372514/000137251423000160/kprx-20231109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001372514-23-000160
- JSON: https://secwatch.observer/filing/0001372514-23-000160.json
- Plain text: https://secwatch.observer/filing/0001372514-23-000160.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.